Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Psychopharmacology|June 21, 1979
Zimelidine: a therapeutic and pharmacokinetic study in depressionA Coppen, V A Ramo Rao, C Swade, et al.Psychopharmacology|May 25, 1979
Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic actionA Coppen, V A Rama Rao, C Swade, et al.The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1978
Mianserin and lithium in the prophylaxis of depressionA Coppen, K Ghose, R Rao, et al.Psychopharmacology|April 14, 1978
Antidepressant activity and pharmacological interactions of ciclazindolK Ghose, V A Rama Rao, J Bailey, et al.Journal of Affective Disorders|July 1, 1987
Seasonal variations in the dexamethasone suppression testC Swade, M Metcalfe, A Coppen, et al.Upsala Journal of Medical Sciences. Supplement|January 1, 1980
Blood platelet 5-hydroxytryptamine accumulation and migraineJ D Carroll, A Coppen, C C Swade, et al.British Journal of Clinical Pharmacology|January 1, 1983
Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disordersK Wood, C Swade, M Abou-Saleh, et al.Journal of Affective Disorders|November 1, 1983
Decreasing lithium dosage reduces morbidity and side-effects during prophylaxisA Coppen, M Abou-Saleh, P Milln, et al.The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1976
A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disordersA Coppen, S A Montgomery, R K Gupta, et al.Journal of Affective Disorders|December 1, 1984
Treatment of bipolar affective illness with zimeldine, a 5-HT uptake inhibitorA Coppen, M T Abou-Saleh, K M Wood, et al.Pageof 9